Maxine Lang, MT ASCP

Core Lab Manager at Boston Heart Diagnostics

Maxine Lang, MT ASCP, has a diverse work experience in the field of medical technology. Maxine started their career at Southwood Hospital in 1995, where they worked as a Medical Technologist until 2000. Following this, they joined Caritas Norwood Hospital in 2006 as a Medical Technologist and stayed in this position until 2013. In 2013, Maxine joined Boston Heart Diagnostics where they held various roles, including Lead Medical Technologist and Medical Technologist. Maxine later became Core Lab Supervisor and currently serves as the Core Lab Manager.

Maxine Lang, MT ASCP, pursued their education in a dedicated manner, gradually building their knowledge and expertise. From 1983 to 1986, they attended North Adams State College, where they earned a Bachelor of Arts (BA) degree in Biology, General. Continuing their academic pursuits, they enrolled at Berkshire Medical Center School of Medical Technology from 1986 to 1987 and obtained a Bachelor of Science (B.S.) degree in Medical Technology. These educational experiences equipped Maxine with a strong foundation in biology and medical technology, setting the stage for their future professional endeavors.

Location

North Attleboro, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Boston Heart Diagnostics

Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management.Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.